Germany
Japan
United Kingdom
China
Anti-Human TACI Goat Polyclonal Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human TACI (TNFRSF13B) |
Antibodies
View as table Download
Anti-Human TWEAK Goat Polyclonal Antibody
| Applications | ELISA |
| Reactivities | Human |
| Immunogen | E.coli derived Recombinant Human TWEAK |
VRK2 Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Internal region (PNSQKVDSQKAATK) |
Pro-EGF Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Internal region (near the N terminus) (SRQERVCNIEKNVS) |
MT-ATP6 Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Test: Human. Expected from seq similarity: Human |
| Immunogen | Internal region (PTSKYLINNRLITTQ) |
ENT1 Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | N Terminus (TSHQPQDRYKAVW) |
BMPR2 Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Internal (DLETNKLDPKEVDK) |
CX3CL1 / fractalkine (aa214-226) Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Internal region (KTSEAPSTQDPST) |
SCARB1 / SR-BI (aa238-250) Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Internal region (NGLSKVDFWHSDQ) |
SCARB1 / SR-BI Goat Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | C Terminus (TSAPKGSVLQEAK) |
Goat Anti-CD13 / ANPEP (aa79-91) Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TLKPDSYRVTLRP, from the internal region (near N terminus) of the protein sequence according to NP_001141.2 |
Goat Anti-CD13 / ANPEP Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-QLEQFKKDNEET, from the internal region (near C terminus) of the protein sequence according to NP_001141.2 |
Goat Anti-cytochrome P450 1A1 Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CQEKQLDENANVQ, from the internal region of the protein sequence according to NP_000490.1 |
Goat Anti-ITGB2 (aa86-99) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-ETQEDHNGGQKQLS, from the internal region of the protein sequence according to NP_000202.2. |
Goat Anti-CD27 (aa161-175) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-QTLADFRQLPARTLS, from the internal region of the protein sequence according to NP_001233.1. |
Goat Anti-CXCR1 (aa26-38) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence DYSPCMLETETLN, from the internal region (near N terminus) of the protein sequence according to NP_000625.1. |
Goat Anti-FZD4 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KIRSNLQKDGTKT, from the internal region of the protein sequence according to NP_036325.2. |
Goat Anti-FCER1A (aa177-189) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TGKVWQLDYESEP, from the internal region of the protein sequence according to NP_001992.1. |
Goat Anti-CD74 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HSLEQKPTDAPPK, from the internal region of the protein sequence according to NP_001020330.1; NP_004346.1. |
Goat Anti-CD74 (aa159-171) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KGSFPENLRHLKN, from the internal region of the protein sequence according to NP_001020330.1; NP_004346.1. |
Goat Anti-CD3E (cytoplasmic) Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RKGQRDLYSGLNQR, from the internal region of the protein sequence according to NP_000724.1. |
Goat Anti-CD3G Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-QDGVRQSRASDKQT, from the internal region of the protein sequence according to NP_000064.1. |
Goat Anti-CX3CR1 (aa34-47) Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DQFPESVTENFEYD, from the internal region (near N terminus) of the protein sequence according to NP_001164645.1; NP_001328.1. |
Goat Anti-GRIA4, Biotinylated Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CKKLDQREYPGSETP., from the internal region of the protein sequence according to NP_000820.3; NP_001070711.1; NP_001070712.1. |
Goat Anti-SDF4 (aa161-175), Biotinylated Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-EYKVKFLASKGHSEK., from the internal region of the protein sequence according to NP_057631.1; NP_057260.2. |
Goat Anti-TGFBI, Biotinylated Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-QLYTDRTEKLRPE., from the internal region of the protein sequence according to NP_000349.1. |
Goat Anti-ACPP / PAP (aa269-282), Biotinylated Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NHMKRATQIPSYKK., from the internal region of the protein sequence according to NP_001127666.1; NP_001090.2. |
Active filters
Filter by
Target Symbol
- CANX (5)
- ALOX5AP (4)
- CADM4 (4)
- GJA1 (4)
- HP (4)
- ACPP (3)
- APOB (3)
- CDH1 (3)
- CDH11 (3)
- FGFR1 (3)
- GABRB3 (3)
- HRH1 (3)
- PNPLA2 (3)
- PTCH1 (3)
- SCARB2 (3)
- TNF (3)
- TSPO (3)
- ABCC4 (2)
- ACVR1 (2)
- ADAM12 (2)
- AMHR2 (2)
- ANPEP (2)
- ANTXR2 (2)
- APOL1 (2)
- ARL6IP5 (2)
- BDNF (2)
- CAV1 (2)
- CCL11 (2)
- CD14 (2)
- CD19 (2)
- CD4 (2)
- CD63 (2)
- CD74 (2)
- CHRNA7 (2)
- CLCN2 (2)
- CNR1 (2)
- COMT (2)
- COX4I1 (2)
- CPT1A (2)
- CPT1B (2)
- CYBB (2)
- CYP26A1 (2)
- DAGLA (2)
- DEFB4A (2)
- DUOX1 (2)
- ENPP1 (2)
- F2R (2)
- FCRL2 (2)
- FGG (2)
- FZD2 (2)
- FZD4 (2)
- GABRA4 (2)
- GCNT3 (2)
- GHRL (2)
- GRIA4 (2)
- GYPA (2)
- HTR3A (2)
- ICAM1 (2)
- KCNJ11 (2)
- KITLG (2)
- LEPR (2)
- MAOB (2)
- PPBP (2)
- PTPRC (2)
- ROR1 (2)
- SCD (2)
- SDF4 (2)
- SFRP1 (2)
- SIL1 (2)
- SLC25A47 (2)
- SLC46A1 (2)
- SLC47A2 (2)
- SRD5A1 (2)
- SRD5A2 (2)
- STX6 (2)
- SYVN1 (2)
- TGFBI (2)
- TMPRSS4 (2)
- TMX1 (2)
- TNFRSF13B (2)
- TNFRSF9 (2)
- TNFSF11 (2)
- TNFSF12 (2)
- TNFSF13B (2)
- WNT3 (2)
- WNT9B (2)
- A4GNT (1)
- ABCA9 (1)
- ABCB5 (1)
- ABCB9 (1)
- ABCC1 (1)
- ABCC11 (1)
- ABCC5 (1)
- ABCC8 (1)
- ABCD3 (1)
- ABCD4 (1)
- ABHD12 (1)
- ACACB (1)
- ACKR1 (1)
- ACSL4 (1)
Reactivities
Isotypes
Clonalities
Conjugates
Pathways
- Neuroactive ligand-receptor interaction (70)
- Cytokine-cytokine receptor interaction (51)
- Calcium signaling pathway (36)
- Metabolic pathways (35)
- Pathways in cancer (33)
- Cell adhesion molecules (CAMs) (28)
- Hematopoietic cell lineage (28)
- MAPK signaling pathway (19)
- Regulation of actin cytoskeleton (17)
- Wnt signaling pathway (16)
- Basal cell carcinoma (15)
- Adipocytokine signaling pathway (14)
- Alzheimer's disease (14)
- Endocytosis (14)
- Melanogenesis (14)
- Natural killer cell mediated cytotoxicity (14)
- Leukocyte transendothelial migration (13)
- T cell receptor signaling pathway (13)
- ABC transporters (12)
- Antigen processing and presentation (11)
- Chemokine signaling pathway (11)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (10)
- Dilated cardiomyopathy (10)
- Focal adhesion (10)
- Primary immunodeficiency (10)
- Prostate cancer (10)
- TGF-beta signaling pathway (10)
- Viral myocarditis (10)
- Adherens junction (9)
- Apoptosis (9)
- Colorectal cancer (9)
- Gap junction (9)
- Hedgehog signaling pathway (9)
- Melanoma (9)
- PPAR signaling pathway (9)
- Type II diabetes mellitus (9)
- Vascular smooth muscle contraction (9)
- Axon guidance (8)
- Fatty acid metabolism (8)
- Huntington's disease (8)
- Hypertrophic cardiomyopathy (HCM) (8)
- Toll-like receptor signaling pathway (8)
- Allograft rejection (7)
- Amyotrophic lateral sclerosis (ALS) (7)
- Androgen and estrogen metabolism (7)
- Asthma (7)
- Jak-STAT signaling pathway (7)
- Neurotrophin signaling pathway (7)
- Type I diabetes mellitus (7)
- Bladder cancer (6)
- Endometrial cancer (6)
- Fc epsilon RI signaling pathway (6)
- Graft-versus-host disease (6)
- Lysosome (6)
- Parkinson's disease (6)
- Retinol metabolism (6)
- Systemic lupus erythematosus (6)
- Tyrosine metabolism (6)
- Autoimmune thyroid disease (5)
- Cardiac muscle contraction (5)
- Complement and coagulation cascades (5)
- Epithelial cell signaling in Helicobacter pylori infection (5)
- ErbB signaling pathway (5)
- GnRH signaling pathway (5)
- NOD-like receptor signaling pathway (5)
- Notch signaling pathway (5)
- Pathogenic Escherichia coli infection (5)
- Riboflavin metabolism (5)
- ECM-receptor interaction (4)
- Fc gamma R-mediated phagocytosis (4)
- Long-term depression (4)
- Oxidative phosphorylation (4)
- RIG-I-like receptor signaling pathway (4)
- Renin-angiotensin system (4)
- SNARE interactions in vesicular transport (4)
- Tryptophan metabolism (4)
- Arachidonic acid metabolism (3)
- Arginine and proline metabolism (3)
- B cell receptor signaling pathway (3)
- Biosynthesis of unsaturated fatty acids (3)
- Drug metabolism - cytochrome P450 (3)
- Glycerolipid metabolism (3)
- Glycine (3)
- Histidine metabolism (3)
- Long-term potentiation (3)
- N-Glycan biosynthesis (3)
- Nicotinate and nicotinamide metabolism (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Phenylalanine metabolism (3)
- Propanoate metabolism (3)
- Thyroid cancer (3)
- Tight junction (3)
- Vibrio cholerae infection (3)
- serine and threonine metabolism (3)
- C21-Steroid hormone metabolism (2)
- Ether lipid metabolism (2)
- Glioma (2)
- Glutathione metabolism (2)
- Glycerophospholipid metabolism (2)
- Insulin signaling pathway (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- O-Glycan biosynthesis (2)
- Pantothenate and CoA biosynthesis (2)
- Prion diseases (2)
- Purine metabolism (2)
- Pyruvate metabolism (2)
- Starch and sucrose metabolism (2)
- Taste transduction (2)
- Ubiquitin mediated proteolysis (2)
- VEGF signaling pathway (2)
- Valine (2)
- beta-Alanine metabolism (2)
- leucine and isoleucine degradation (2)
- p53 signaling pathway (2)
- Acute myeloid leukemia (1)
- Amino sugar and nucleotide sugar metabolism (1)
- Ascorbate and aldarate metabolism (1)
- Base excision repair (1)
- Butanoate metabolism (1)
- Dorso-ventral axis formation (1)
- Fatty acid biosynthesis (1)
- Glycolysis / Gluconeogenesis (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Inositol phosphate metabolism (1)
- Keratan sulfate biosynthesis (1)
- Limonene and pinene degradation (1)
- Lysine degradation (1)
- Maturity onset diabetes of the young (1)
- Nitrogen metabolism (1)
- Oocyte meiosis (1)
- Phosphatidylinositol signaling system (1)
- Porphyrin and chlorophyll metabolism (1)
- Primary bile acid biosynthesis (1)
- Small cell lung cancer (1)
- Sphingolipid metabolism (1)
- alpha-Linolenic acid metabolism (1)